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• Native vertebral osteomyelitis (NVO) is an 
infection of the vertebrae
• Once diagnosed, antibiotics are prescribed 
targeting the causative agent of infection
• Treatment is typically monitored by 
concurrent ESR and CRP laboratory testing
• Importantly, the necessity of utilizing both 
inflammatory markers concurrently is 
unclear and Choosing Wisely guidance 
suggests using both labs is redundant
• The primary aim of this study is to review 
the utility of concurrent ESR and CRP 
testing in NVO 
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• 41 patients underwent 332 ESR and CRP tests (173 
ESR, 159 CRP) during their treatment course
• Of the 148 ESR and CRP tests performed concurrently: 
8.1% (12/148) of concurrent ESR/CRP tests were in 
agreement for normal results, 67.6% (100/148) were in 
agreement for abnormal results and 24.3% (36/148) 
had disparate results
• The average treatment course was 47 days (range, 36-
147): 46 days for disparate results, 50 days for 
instances of agreement of abnormal results, and 44 
days for instances of agreement of normal results 
(p=NS)
• 19.5% (8/41) of patients experienced a 30-day hospital 
readmission and underwent 32 instances of concurrent 
ESR/CRP testing: 3.1% (1/32) instances were in 
agreement for normal results, 75.0% (24/32) were in 
agreement for abnormal results and 21.9% (7/32) had 
disparate results (p=NS)
• The percent agreement between ESR and 
CRP was 75.7 and the percent 
disagreement was 24.3
• There was no statistically significant 
difference in 30-day readmissions for 
patients with concurrent ESR and CRP 
testing when the results were in agreement 
or disparate 
• The data suggests that concurrent ESR and 
CRP tests may not be necessary for 
monitoring treatment of NVO
ANOVA statistical analysis utilized to compare concurrent 
ESR and CRP results to readmissions within 30 days.
• Concurrent ESR and CRP tests for 
monitoring treatment of NVO may not be 
helpful
• A limitation of the data is the small sample 
size and further research should be 
performed on a larger sample size
• Additionally, further studies should extend 
the follow-up period to one year to attempt 
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Inclusion and exclusion criteria were set up to 
standardize the candidates in this study:
Inclusion
• 18 years or older
• Admitted to LVH-CC or LVH-
M (8/1/15-7/31/17)
• Received inpatient ID 
consult
• Diagnosed with NVO
• Received outpatient 
parental antimicrobial 
therapy
• Received IV/oral 
antimicrobial therapy
• At least one concurrent 
testing of ESR and CRP
Exclusion
• Lack of microbiological 
diagnosis
• Previous spinal 
instrumentation (one year)
• Spinal tuberculosis, spinal 
brucellosis, NVO caused by 
yeasts and molds and spinal 
infections caused by seeding 
from a local site of infection
• Only one episode of NVO 
will be included
• Cases with possible culture 
contaminants
Gender Male 70.73%Female 29.27%
Race
Black or African American 2.44%
Missing or Unavailable 2.44%
Other 2.44%
Patient declined or refused 2.44%
Unknown 2.44%
White or Caucasian 87.80%
Ethnicity
Hispanic or Latino 2.44%
Not Hispanic or Latino 87.80%
Patient Refused 2.44%
Unknown 7.32%
8%
68%
24%
Both normal
Both abnormal
Disparate results
